期刊文献+

巨噬细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子对小鼠乳腺癌4T1细胞迁移及血管内皮生长因子A表达的影响 被引量:2

Effect of M-CSF and GM-CSF on migration and VEGF-A expression of breast cancer cell line 4T1
原文传递
导出
摘要 目的 探讨巨噬细胞集落刺激因子(M-CSF)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)对乳腺癌4T1细胞迁移及血管内皮生长因子(VEGF)-A表达的影响.方法 分别用5、10 ng/ml M-CSF和GM-CSF处理小鼠乳腺癌4T1细胞株,采用实时荧光定量PCR方法检测4T1细胞中细胞因子VEGF-AmRNA表达量的变化.划痕实验和Transwell实验检测用5 ng/ml M-CSF、5 ng/ml GM-CSF和10 ng/mlVEGF-A对4T1细胞迁移和侵袭能力的影响.结果 经5、10ng/ml M-CSF分别处理4T1细胞后VEGF-AmRNA在12h和24 h的相对表达量分别为17.81±2.49和17.48±5.43、5.15±2.59和5.45±4.28;经5、10 ng/ml GM-CSF分别处理4T1细胞后VEGF-A mRNA在12h和24 h的相对表达量分别为9.77±2.39和7.61±2.80、6.53±2.41和6.30±2.89.与无细胞因子处理的对照组相比,除10 ng/ml GM-CSF处理4T1细胞24 h组VEGF-A mRNA表达水平差异无统计学意义(P>0.05)外,其他各组VEGF-A mRNA表达水平差异均有统计学意义(均P< 0.05),处理细胞12h时VEGF-A的表达较24 h时更明显(均P< 0.01).划痕实验显示M-CSF和GM-CSF可促进4T1细胞的迁移,但VEGF-A对4T1细胞的迁移无影响.Transwell实验发现,用M-CSF、GM-CSF和VEGF-A处理的实验组中4T1细胞的穿膜数量多于无细胞因子处理的对照组(均P< 0.05).结论 M-CSF和GM-CSF可促进小鼠乳腺癌4T1细胞迁移及VEGF-A的表达. Objective To investigate the effect of M-CSF and GM-CSF on migration and expression of VEGF-A in breast cancer cell line 4T1.Methods Real-time PCR was used to detect VEGF-A mRNA expression in 4T1 cells treated by 5 ng/ml or 10 ng/ml M-CSF or GM-CSF.Ability of migration and metastasis of 4T1 cells were analyzed by scratch and Transwell assays.Results The relative expression of VEGF-A mRNA at 12 h and 24 h in 4T1 cells treated by 5 ng/ml or 10 ng/ml M-CSF were 17.81±2.49 and 17.48± 5.43,5.15±2.59 and 5.45±4.28,respectively,while those treated by GM-CSF were 9.77±2.39 and 7.61±2.80,6.53±2.41 and 6.30±2.89,respectively.M-CSF and GM-CSF can promote the expression of VEGF-A in 4T1 cells (P 〈 0.05).The relative expression of VEGF-A was higher in 4T1 cells treated for 12 h than that for 24 h (P 〈 0.01).M-CSF,GM-CSF and VEGF-A can promote metastasis of 4T1 cells (all P 〈 0.05),whereas no gross migration of 4T1 cells was showed by VEGF-A treatment.Conclusion M-CSF and GM-CSF can promote the migration and expression of VEGF-A in breast cancer cell line 4T1.
出处 《肿瘤研究与临床》 CAS 2014年第8期510-513,共4页 Cancer Research and Clinic
  • 相关文献

参考文献11

  • 1Fan F,Schimming A,Jaeger D,et al.Targeting the tumor microenvironment:focus on angiogenesis[J].J Oncol,2012,2012:281261.
  • 2Hershman D,Neugut AI,Jacobson JS,et al.Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colonystimulating factors during breast cancer adjuvant chemotherapy[J].JNatl Cancer Inst,2007,99:196-205.
  • 3Broggini M,Marchini SV,Galliera E,et al.Aplidine,a new anticancer agent of marine origin,inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4[J].Leukemia,2003,17:52-59.
  • 4Aguayo A,Estey E,Kantarjian H,et al.Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia[J].Blood,1999,94:3717-3721.
  • 5Bellamy WT,Richter L,Frutiger Y,et al.Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies[J].Cancer Res,1999,59:728-733.
  • 6祖璎玲(综述),房佰俊(审校).血管内皮生长因子与白血病关系的研究进展[J].白血病.淋巴瘤,2013,22(4):251-253. 被引量:3
  • 7Bertolini F.Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology[J].Breast,2009,18:S48-50.
  • 8Bellou S,Pentheroudakis G,Murphy C,et al.Anti-angiogenesis in cancer therapy:Hercules and hydra[J].Cancer Lett,2013,338:219-228.
  • 9Garcia-Roman J,Zentella-Dehesa A.Vascular permeability changes involved in tumor metastasis[J].Cancer Lett,2013,335:259-269.
  • 10Eveno C,Pocard M.VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis[J].Cell Adh Migr,2012,6:569-573.

二级参考文献53

  • 1石太新,李树军,张文林.儿童急性白血病骨髓细胞中血管内皮生长因子及其受体的表达[J].白血病.淋巴瘤,2006,15(4):255-256. 被引量:1
  • 2李锋,陈朴,邹善华.慢性髓细胞性白血病与血管生成因子关系[J].中国癌症杂志,2004,14(5):462-465. 被引量:4
  • 3Toi M, Inada K, Suzuki H, et al. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression [J]. Breast Cancer Res Treat, 1995,36(2): 193-204.
  • 4Lchn E, Liotta L. Molecular insights into cancer invasion:strategies for prevention and intervention [J]. Cancer Res, 1995,55(3):1865.
  • 5Folkman J. Angi ogenesis in cancer, vascular, rheumatoid and other disease [J].Nature Med, 1995,1(4):27-31.
  • 6BreierG, RisauW. The role of vascular endothelial growth factor in blood vessel formation [J]. Trends Cell Biol, 1996,6:454-458.
  • 7Shalaby F, Rossant J, Yameguchi T P, et al. Failure of blood- island formation and vasculogenesis in FLK- 1 -deficient mice [J]. Nature, 1995,376:62-66.
  • 8SatoTN, TozawaY, DeutschU, et al. Distinct roles of the receptor tyrosine kinases Tie- 1 and Tie-2 in blood vessel formation [J]. Nature,1995,376:70-74.
  • 9Maisonpierre P C, Suri C, Jones P F, et al.Angiopoietin- 2, a natural antagonist for Tie 2 that disrupts in vivo angiogenesis[J].Science, 1997, 277:55-60.
  • 10Toi M, Hoshima S, Takayanagi T, et al.Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer[J]. JpnJ Cancer Res, 1994,85(10):1045.

共引文献3

同被引文献36

  • 1尹雅薇.苯中毒致再生障碍性贫血的细胞免疫功能研究[J].求医问药(下半月),2013(6):110-111. 被引量:1
  • 2苏淑芳.72例儿童急性再生障碍性贫血临床分析[D].郑州大学2012
  • 3Alibolandi M, Sadeghi F, Abnous K, et al. The chemo- therapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model[J]. Eur JPharm Biopharm, 2015,94(5) : 521.
  • 4Gao ZG, Tian L, Hu J, et al. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles[J]. J Control Release, 2011,152 ( 1 ) : 84.
  • 5Li MQ, Tang ZH, Zhang Y, et al. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparti- cles suppresses breast cancer growth and metastasis[J]. Ac- ta Biomater, 2015, doi : 10.1016/j.actbio.2015.02.022.
  • 6Li MQ , Tang ZH, Zhang DW, et al. Doxorubicin-load- ed polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models[J]. Bioma- terials, 2015, doi : 10.1016/j .biomaterials. 2015.02.002.
  • 7Wang J, Ma W, Tu P, et al. Synergistically improved an- ti-tumor efficacy by co-delivery doxorubicin and curcum- in polymeric micelles[J]. Macromol Biosci, 2015, 15 (9) : 1 252.
  • 8Kim J, Park EJ. Cytotoxic anticancer candidates from nat- ural resources[J]. Curt Med Chem Anti-cancer Agents, 2002,2(4) :485.
  • 9Li Y, Jin M, Shao S, et al. Small-sized polymeric mi- celles incorporating docetaxel suppress distant metastases in the clinically-relevant 4TI mouse breast cancer model [J]. BMC Cancer, 2014, doi : i0.118611471-2407-14-329.
  • 10Lu X, Zhang F, Qin L, et al. Polymeric micelles as a drug delivery system enhance cytotoxicity of vinorelbine through more intercellular accumulation[J]. Drug Deliv, 2010,17(4):255.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部